GenMont Biotech (Taiwan) Price Prediction
| 3164 Stock | TWD 20.05 0.10 0.50% |
Oversold Vs Overbought
31
Oversold | Overbought |
Using GenMont Biotech hype-based prediction, you can estimate the value of GenMont Biotech from the perspective of GenMont Biotech response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in GenMont Biotech to buy its stock at a price that has no basis in reality. In that case, they are not buying GenMont because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
GenMont Biotech after-hype prediction price | TWD 20.05 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
GenMont |
GenMont Biotech After-Hype Price Prediction Density Analysis
As far as predicting the price of GenMont Biotech at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in GenMont Biotech or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of GenMont Biotech, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
GenMont Biotech Estimiated After-Hype Price Volatility
In the context of predicting GenMont Biotech's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on GenMont Biotech's historical news coverage. GenMont Biotech's after-hype downside and upside margins for the prediction period are 19.18 and 20.92, respectively. We have considered GenMont Biotech's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
GenMont Biotech is very steady at this time. Analysis and calculation of next after-hype price of GenMont Biotech is based on 3 months time horizon.
GenMont Biotech Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as GenMont Biotech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading GenMont Biotech backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with GenMont Biotech, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.26 | 0.87 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
20.05 | 20.05 | 0.00 |
|
GenMont Biotech Hype Timeline
GenMont Biotech is presently traded for 20.05on Taiwan Stock Exchange of Taiwan. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. GenMont is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is presently at -0.26%. %. The volatility of related hype on GenMont Biotech is about 0.0%, with the expected price after the next announcement by competition of 20.05. About 37.0% of the company shares are owned by insiders or employees . The company has Price-to-Book (P/B) ratio of 1.58. In the past many companies with similar price-to-book ratios have beat the market. GenMont Biotech last dividend was issued on the 24th of June 2022. The entity had 110:100 split on the 15th of June 2010. Assuming the 90 days trading horizon the next anticipated press release will be in 5 to 10 days. Check out GenMont Biotech Basic Forecasting Models to cross-verify your projections.GenMont Biotech Related Hype Analysis
Having access to credible news sources related to GenMont Biotech's direct competition is more important than ever and may enhance your ability to predict GenMont Biotech's future price movements. Getting to know how GenMont Biotech's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how GenMont Biotech may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| 6409 | Voltronic Power Technology | 0.00 | 0 per month | 0.00 | (0.05) | 4.98 | (4.82) | 15.05 | |
| 6752 | Galaxy Software Services | 0.00 | 0 per month | 1.50 | 0.01 | 4.13 | (2.52) | 13.11 | |
| 3360 | Sunnic Technology Merchandise | 0.00 | 0 per month | 2.53 | 0.01 | 5.49 | (4.88) | 16.05 | |
| 4132 | Golden Biotechnology | 0.00 | 0 per month | 0.00 | (0.12) | 1.75 | (2.88) | 19.95 | |
| 3479 | Avalue Technology | 0.00 | 0 per month | 0.00 | (0.1) | 2.27 | (2.69) | 10.97 | |
| 2314 | Microelectronics Technology | 0.00 | 0 per month | 1.87 | 0.03 | 9.68 | (3.88) | 14.42 | |
| 8114 | Posiflex Technology | 0.00 | 0 per month | 1.71 | 0.20 | 7.82 | (3.10) | 13.80 |
GenMont Biotech Additional Predictive Modules
Most predictive techniques to examine GenMont price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for GenMont using various technical indicators. When you analyze GenMont charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About GenMont Biotech Predictive Indicators
The successful prediction of GenMont Biotech stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as GenMont Biotech, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of GenMont Biotech based on analysis of GenMont Biotech hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to GenMont Biotech's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to GenMont Biotech's related companies.
Story Coverage note for GenMont Biotech
The number of cover stories for GenMont Biotech depends on current market conditions and GenMont Biotech's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that GenMont Biotech is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about GenMont Biotech's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
GenMont Biotech Short Properties
GenMont Biotech's future price predictability will typically decrease when GenMont Biotech's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of GenMont Biotech often depends not only on the future outlook of the potential GenMont Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. GenMont Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 86.4 M |
Additional Tools for GenMont Stock Analysis
When running GenMont Biotech's price analysis, check to measure GenMont Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GenMont Biotech is operating at the current time. Most of GenMont Biotech's value examination focuses on studying past and present price action to predict the probability of GenMont Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GenMont Biotech's price. Additionally, you may evaluate how the addition of GenMont Biotech to your portfolios can decrease your overall portfolio volatility.